Form 4: Elanco Executive Rajeev A. Modi Reports Stock Transactions

Elanco Animal Health Inc. Executive Vice President Rajeev A. Modi reports acquisition and disposal of company stock and stock options.

Summary

• On March 1, 2024, Rajeev A. Modi, an Executive Vice President at Elanco Animal Health Inc., reported transactions involving Elanco's common stock and stock options.
• Modi acquired 19,651 shares of common stock through a grant of restricted stock units at $0, vesting in three tranches from March 1, 2025, to March 1, 2027.
• He also disposed of 3,616 shares to cover tax liabilities related to previously awarded restricted stock units at a price of $16.03.
• Additionally, Modi was granted stock options for 42,858 shares, exercisable in three tranches from March 1, 2025, to March 1, 2027, at an exercise price of $16.03.
• Following these transactions, Modi beneficially owns 77,272 shares of common stock and stock options for 42,858 shares.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine disclosure of stock transactions by an executive. The grants suggest a positive outlook from the company's perspective, but the disposal of shares for tax purposes is a standard procedure.

Positives

• The grant of restricted stock units and stock options to a key executive like Rajeev A. Modi aligns his interests with the long-term performance of Elanco.
• The vesting schedule of the grants (March 1, 2025, March 1, 2026, and March 1, 2027) encourages continued service and commitment from the executive.

Future Outlook

The document does not contain specific forward-looking statements, but the vesting schedule of the stock grants suggests an expectation of continued employment and contribution from the executive.

Industry Context

Executive stock transactions are a common practice in publicly traded companies like Elanco to incentivize and retain key personnel. These transactions are closely monitored by investors for insights into management's confidence in the company's future prospects.

Comparison to Industry Standards

• Stock option and restricted stock unit grants are standard compensation practices in the animal health and pharmaceutical industries.
• Companies like Zoetis and Merck Animal Health also utilize similar equity-based compensation plans to align executive interests with shareholder value.
• The vesting schedules and exercise prices are generally in line with industry norms for executive compensation packages.

Stakeholder Impact

• The stock transactions may have a minor impact on shareholders, as they reflect insider activity.
• The grants of stock options and restricted stock units incentivize the executive to contribute to the company's success, potentially benefiting employees and other stakeholders.

Key Dates